uniQure (QURE) Common Equity (2015 - 2026)
uniQure (QURE) recorded quarterly Common Equity of $149.3 million in Q1 2026, down 24.92% quarter-over-quarter from $198.9 million in Q4 2025, and up 343.34% on a YoY basis from $33.7 million in Q1 2025.
uniQure (QURE) Common Equity (2015 - 2026) Analysis & Trends
uniQure's Common Equity history runs 12 years deep, the most recent figure standing at $149.3 million for Q1 2026.
- In Q1 2026, Common Equity rose 343.34% year-over-year to $149.3 million; the TTM figure through Mar 2026 stood at $149.3 million (up 343.34% YoY), while the FY2025 annual figure was $198.9 million, up 3045.81% from the prior year.
- Common Equity was $149.3 million for Q1 2026 at uniQure, down from $198.9 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $546.0 million in Q1 2022 to a low of -$6.8 million in Q4 2024.
- Historically, Common Equity has averaged $239.5 million across 5 years, with a median of $207.7 million in 2023.
- Biggest YoY gain for Common Equity was 3045.81% in 2025; the steepest drop was 104.12% in 2025.
- A 5-year view of Common Equity shows it stood at $476.0 million in 2022, then tumbled by 56.37% to $207.7 million in 2023, then sank by 103.25% to -$6.8 million in 2024, then soared by 3045.81% to $198.9 million in 2025, then retreated by 24.92% to $149.3 million in 2026.
- The last three Common Equity figures came in at $149.3 million (Q1 2026), $198.9 million (Q4 2025), and $228.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 35.63 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.42 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 13.21 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 14.38 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 11.87 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | uniQure | 2.88 Bn | 2.88 Bn | 3.34 Mn | 149.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 149.34 Mn |
| Dec 31, 2025 | 198.90 Mn |
| Sep 30, 2025 | 228.75 Mn |
| Jun 30, 2025 | -4.00 Mn |
| Mar 31, 2025 | 33.69 Mn |
| Dec 31, 2024 | -6.75 Mn |
| Sep 30, 2024 | 55.82 Mn |
| Jun 30, 2024 | 97.11 Mn |
| Mar 31, 2024 | 146.75 Mn |
| Dec 31, 2023 | 207.67 Mn |
| Sep 30, 2023 | 268.78 Mn |
| Jun 30, 2023 | 353.32 Mn |
| Mar 31, 2023 | 412.77 Mn |
| Dec 31, 2022 | 476.01 Mn |
| Sep 30, 2022 | 421.17 Mn |
| Jun 30, 2022 | 486.49 Mn |
| Mar 31, 2022 | 546.00 Mn |
| Dec 31, 2021 | 595.78 Mn |
| Sep 30, 2021 | 590.76 Mn |
| Jun 30, 2021 | 633.61 Mn |